2026-05-17T06:30:10Z https://www.eurjchem.com/index.php/eurjchem/oai

oai:ojs.www.eurjchem.com:article/1667 2018-03-11T13:45:35Z eurjchem:REW driver

Quality by design (QbD) and process analytical technology (PAT) applications in pharmaceutical industry Calhan, Selda Dogan Eker, Ebru Derici Sahin, Nefise Ozlen Drug Spectroscopy Quality by design Product development Pharmaceutical industry Process analytical technology Quality by Design (QbD) for the pharmaceutical industry includes the design, development and production control of products and production processes from the beginning to the end of the product development phase for ensuring the consistent quality of a pharmaceutical product. The QbD is a systematic scientific approach aimed at meeting the needs of the patient in the desired and targeted quality and aiming to produce the same quality pharmaceutical product in this direction. Process Analytical Technology, which is assessed in that regard, is part of a design quality approach that is used to design, analyze, and control real-time measurements of quality and performance criteria for raw and processed materials to achieve the desired final product. This scientific and systematic approach to pharmaceutical product development, which is also acknowledged and supported by the health authorities, serves to the changing and developing pharmaceutical sector. Atlanta Publishing House LLC 2017-12-31 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf https://www.eurjchem.com/index.php/eurjchem/article/view/1667 10.5155/eurjchem.8.4.430-433.1667 European Journal of Chemistry; Vol. 8 No. 4 (2017): December 2017; 430-433 2153-2257 2153-2249 eng https://www.eurjchem.com/index.php/eurjchem/article/view/1667/pdf_1667